Loveworld Medical Centre Advances Precision Cancer Care in Africa

Loveworld Medical Centre is strengthening Nigeria’s position in the emerging field of precision oncology with the International Symposium on Radiopharmaceutical Therapy (ISRT) 2026, a major scientific gathering focused on advancing radiotheranostics, nuclear medicine and molecular imaging across Africa.

Held on August 28–29, 2026, in Lagos, the symposium brings together healthcare professionals, researchers, nuclear medicine specialists, radiopharmacists, oncologists and other experts from across Africa to explore how radiopharmaceutical therapy can transform cancer diagnosis and treatment on the continent.

The symposium is an official conference of the **World Association of Radiopharmaceutical and Molecular Therapy (WARMTH)** and is organised by Loveworld Medical Centre in collaboration with the **International Centers for Precision Oncology (ICPO)**, the **Chris Oyakhilome Foundation International (COFI)** and other strategic partners.

At the heart of the initiative is the growing recognition that Africa needs to expand access to advanced and targeted approaches to cancer care. Radiotheranostics, which combines molecular imaging with targeted radionuclide therapy, is increasingly emerging as an important frontier in personalised cancer diagnosis and treatment.

Loveworld Medical Centre has become an important platform for advancing specialised healthcare, medical education and professional capacity in Nigeria. Under the leadership of **Dr. Deola Phillips, Executive Minister, Ministry of Healing, Health and Social Services and Chairman of Loveworld Medical Centre**, the institution has continued to promote a vision of healthcare that combines clinical excellence, innovation, professional development and service to humanity.

Dr. Phillips’ leadership provides an important institutional foundation for the symposium, particularly at a time when African health systems are seeking new approaches to complex diseases such as cancer. Her role in advancing healthcare development and supporting platforms that bring global medical expertise to Nigeria underscores Loveworld Medical Centre’s commitment to contributing to the transformation of healthcare delivery on the continent.

Working alongside her, **Dr. Emeka Eze, Chief Medical Director of Loveworld Medical Centre and Chairman of ISRT 2026**, has provided strategic and professional leadership for the symposium. His role has been instrumental in bringing together medical professionals and international stakeholders around the shared objective of strengthening Africa’s capacity in radiopharmaceutical therapy, nuclear medicine and precision oncology.

Through ISRT 2026, Dr. Eze is helping position Lagos as a meeting point for scientific exchange and collaboration in an area of medicine with significant potential to improve cancer outcomes. The symposium provides an opportunity for practitioners to share knowledge, examine emerging technologies and explore practical pathways for integrating advanced theranostic services into African healthcare systems.

WARMTH contributes an important international dimension to the programme through its focus on radiopharmaceutical and molecular therapy. The association provides a professional platform for knowledge exchange, scientific collaboration and the advancement of expertise in a field that is rapidly changing the way cancer and other diseases are diagnosed and treated.

The **International Centers for Precision Oncology (ICPO)** brings expertise in precision medicine and multidisciplinary cancer care, supporting efforts to strengthen education, research, clinical practice and international collaboration. Its participation reinforces the symposium’s focus on translating scientific advances into practical approaches to patient care.

The **Chris Oyakhilome Foundation International (COFI)** complements these efforts through its broader humanitarian commitment to health, education and social development. Its involvement reflects the importance of ensuring that advances in medical science are ultimately connected to improved health outcomes and human wellbeing.

The two-day programme features scientific sessions and practical learning opportunities, including training in radiopharmacy and clinical theragnostics. Participants are examining challenges facing nuclear medicine in Africa, opportunities for radiopharmaceutical therapy, workforce development, regulatory issues, molecular imaging and the future of precision oncology.

A major highlight is the **Saul Hertz Best Abstract Award**, established in honour of Dr. Saul Hertz, the pioneer of radioiodine therapy and widely recognised as the Father of Theranostics. Sponsored by his daughter, Barbara Hertz, curator of the Dr. Saul Hertz Archives, the award recognises outstanding early-career researchers whose work advances nuclear medicine, radiopharmaceutical therapy, molecular imaging and precision oncology.

With healthcare professionals from across East and West Africa participating, ISRT 2026 represents an effort to strengthen the continent’s scientific and clinical capacity while creating new pathways for collaboration.

For Nigeria, the symposium offers an opportunity to demonstrate that the country can play a leading role in Africa’s emerging precision medicine ecosystem. For Loveworld Medical Centre, it further reinforces its commitment under the leadership of Dr. Deola Phillips and Dr. Emeka Eze to advancing healthcare innovation, professional capacity and access to modern medical solutions.

As cancer continues to pose a major health challenge across Africa, initiatives such as ISRT 2026 are helping move the conversation toward earlier diagnosis, targeted treatment, scientific collaboration and a future in which precision cancer care becomes increasingly accessible to patients across the continent.